宫颈癌治疗后下肢淋巴水肿预防进展

doi:10.12280/gjfckx.20200650

摘要/Abstract

摘要：

宫颈癌是最常见的女性生殖系统恶性肿瘤,发病率在女性恶性肿瘤中居第2位,严重威胁患者的生命健康。下肢淋巴水肿是宫颈癌治疗后较为常见的并发症,常表现为治疗后发生的患侧下肢慢性进行性无痛性肿胀,并伴有下肢沉重感和疼痛感,严重影响了患者的生活质量。前哨淋巴结活检、新的放疗方法等的应用对早期诊断下肢淋巴水肿起到了十分积极的作用。患者在宫颈癌治疗后进行定期的随访也有助于下肢淋巴水肿的早期诊断和及时治疗。预防下肢淋巴水肿对宫颈癌患者意义重大,临床医生应对下肢淋巴水肿患者引起充分的重视。需在早期对患者进行明确的诊断和有效的干预,以达到延缓下肢淋巴水肿发展、提高患者生活质量的目的。

关键词: 宫颈肿瘤, 癌, 淋巴水肿, 前哨淋巴结活组织检查, 放射疗法

Abstract:

Cervical cancer is the most common malignant tumor of the female reproductive system, with the incidence rate ranking second among female malignant tumors, which seriously threatens patients′ life and health. Lower limb lymphedema is a common complication after cervical cancer treatment, which often manifests as chronic progressive painless swelling of the affected lower limbs after treatment, accompanied by heaviness and pain and seriously affects the quality of life of patients. The application of sentinel lymph node biopsy and new radiotherapy methods has played a very positive role in the early diagnosis of lower limb lymphedema. Regular follow-up of patients after cervical cancer treatment is also helpful for early diagnosis and timely treatment of lower limb lymphoedema. Prevention of lower limb lymphoedema is of great significance to cervical cancer patients, so clinicians should pay sufficient attention to patients with lower limb lymphoedema. Early diagnosis and effective intervention should be carried out in order to delay the development of lower limb lymphedema and improve patients′ quality of life.

Key words: Uterine cervical neoplasms, Carcinoma, Lymphedema, Sentinel lymph node biopsy, Radiotherapy

张赫, 孔为民. 宫颈癌治疗后下肢淋巴水肿预防进展[J]. 国际妇产科学杂志, 2021, 48(2): 139-143.

ZHANG He, KONG Wei-min. Progress in Prevention of Lower Extremities Lymphedema after Treatment of Cervical Cancer[J]. Journal of International Obstetrics and Gynecology, 2021, 48(2): 139-143.

参考文献 29

[1]	张佳佳, 张易. 宫颈癌术后下肢中度淋巴水肿延迟治疗的质性研究[J]. 护理研究, 2020,34(2):303-306. doi: 10.12102/j.issn.1009-6493.2020.02.025.
[2]	Kuroda K, Yamamoto Y, Yanagisawa M, et al. Risk factors and a prediction model for lower limb lymphedema following lymphadenectomy in gynecologic cancer: a hospital-based retrospective cohort study[J]. BMC Womens Health, 2017,17(1):50. doi: 10.1186/s12905-017-0403-1. doi: 10.1186/s12905-017-0403-1 pmid: 28743274
[3]	Hayes SC, Janda M, Ward LC, et al. Lymphedema following gynecological cancer: Results from a prospective, longitudinal cohort study on prevalence, incidence and risk factors[J]. Gynecol Oncol, 2017,146(3):623-629. doi: 10.1016/j.ygyno.2017.06.004. pmid: 28624154
[4]	Dean SM, Valenti E, Hock K, et al. The clinical characteristics of lower extremity lymphedema in 440 patients[J]. J Vasc Surg Venous Lymphat Disord, 2020,8(5):851-859. doi: 10.1016/j.jvsv.2019.11.014. pmid: 31992537
[5]	Jiang X, Nicolls MR, Tian W, et al. Lymphatic Dysfunction, Leukotrienes, and Lymphedema[J]. Annu Rev Physiol, 2018,80:49-70. doi: 10.1146/annurev-physiol-022516-034008. pmid: 29029593
[6]	Executive Committee. The Diagnosis and Treatment of Peripheral Lymphedema: 2016 Consensus Document of the International Society of Lymphology[J]. Lymphology, 2016,49(4):170-184. pmid: 29908550
[7]	Pappalardo M, Lin C, Ho OA, et al. Staging and clinical correlations of lymphoscintigraphy for unilateral gynecological cancer-related lymphedema[J]. J Surg Oncol, 2020,121(3):422-434. doi: 10.1002/jso.25817. doi: 10.1002/jso.25817 pmid: 31875981
[8]	Landoni F, Colombo A, Milani R, et al. Randomized study between radical surgery and radiotherapy for the treatment of stage IB-IIA cervical cancer: 20-year update[J]. J Gynecol Oncol, 2017,28(3):e34. doi: 10.3802/jgo.2017.28.e34. doi: 10.3802/jgo.2017.28.e34 pmid: 28382797
[9]	Carlson JW, Kauderer J, Hutson A, et al. GOG 244-The lymphedema and gynecologic cancer (LEG) study: Incidence and risk factors in newly diagnosed patients[J]. Gynecol Oncol, 2020,156(2):467-474. doi: 10.1016/j.ygyno.2019.10.009. doi: 10.1016/j.ygyno.2019.10.009 pmid: 31837831
[10]	Dessources K, Aviki E, Leitao MM Jr. Lower extremity lymphedema in patients with gynecologic malignancies[J]. Int J Gynecol Cancer, 2020,30(2):252-260. doi: 10.1136/ijgc-2019-001032. pmid: 31915136
[11]	Dayan JH, Ly CL, Kataru RP, et al. Lymphedema: Pathogenesis and Novel Therapies[J]. Annu Rev Med, 2018,69:263-276. doi: 10.1146/annurev-med-060116-022900. doi: 10.1146/annurev-med-060116-022900 pmid: 28877002
[12]	O′Donnell TF Jr, Rasmussen JC, Sevick-Muraca EM. New diagnostic modalities in the evaluation of lymphedema[J]. J Vasc Surg Venous Lymphat Disord, 2017,5(2):261-273. doi: 10.1016/j.jvsv.2016.10.083. pmid: 28214496
[13]	Shaitelman SF, Cromwell KD, Rasmussen JC, et al. Recent progress in the treatment and prevention of cancer-related lymphedema[J]. CA Cancer J Clin, 2015,65(1):55-81. doi: 10.3322/caac.21253. doi: 10.3322/caac.21253 pmid: 25410402
[14]	Wisner K, Ahmad S, Holloway RW. Indications and techniques for robotic pelvic and para-aortic lymphadenectomy with sentinel lymph node mapping in gynecologic oncology[J]. Best Pract Res Clin Obstet Gynaecol, 2017,45:83-93. doi: 10.1016/j.bpobgyn.2017.04.006. pmid: 28533155
[15]	Hara H, Mihara M. Multilymphosome injection indocyanine green lymphography can detect more lymphatic vessels than lymphoscintigraphy in lymphedematous limbs[J]. J Plast Reconstr Aesthet Surg, 2020,73(6):1025-1030. doi: 10.1016/j.bjps.2020.01.021. doi: 10.1016/j.bjps.2020.01.021 pmid: 32115379
[16]	Carter J, Huang HQ, Armer J, et al. GOG 244 - The LymphEdema and Gynecologic cancer (LEG) study: The association between the gynecologic cancer lymphedema questionnaire (GCLQ) and lymphedema of the lower extremity (LLE)[J]. Gynecol Oncol, 2019,155(3):452-460. doi: 10.1016/j.ygyno.2019.10.009. doi: 10.1016/j.ygyno.2019.09.027 pmid: 31679787
[17]	Sanft T, Denlinger CS, Armenian S, et al. NCCN Guidelines Insights: Survivorship, Version 2.2019[J]. J Natl Compr Canc Netw, 2019,17(7):784-794. doi: 10.6004/jnccn.2019.0034. pmid: 31319383
[18]	Akhavan S, Aminimoghaddam S, Rahmani M. Sentinel lymph node in cervical cancer[J]. Med J Islam Repub Iran, 2017,31:50. doi: 10.14196/mjiri.31.50. doi: 10.14196/mjiri.31.50 pmid: 29445679
[19]	Hareyama H, Hada K, Goto K, et al. Prevalence, classification, and risk factors for postoperative lower extremity lymphedema in women with gynecologic malignancies: a retrospective study[J]. Int J Gynecol Cancer, 2015,25(4):751-757. doi: 10.1097/igc.0000000000000405. pmid: 25723779
[20]	Cibula D, Dusek J, Jarkovsky J, et al. A prospective multicenter trial on sentinel lymph node biopsy in patients with early-stage cervical cancer (SENTIX)[J]. Int J Gynecol Cancer, 2019,29(1):212-215. doi: 10.1136/ijgc-2018-000010. doi: 10.1136/ijgc-2018-000010 pmid: 30640706
[21]	Yahata H, Kobayashi H, Sonoda K, et al. Prognostic outcome and complications of sentinel lymph node navigation surgery for early-stage cervical cancer[J]. Int J Clin Oncol, 2018,23(6):1167-1172. doi: 10.1007/s10147-018-1327-y. pmid: 30094694
[22]	Togami S, Kubo R, Kawamura T, et al. Risk factors for lymphatic complications following lymphadenectomy in patients with endometrial cancer[J]. Taiwan J Obstet Gynecol, 2020,59(3):420-424. doi: 10.1016/j.tjog.2020.03.015. doi: 10.1016/j.tjog.2020.03.015 pmid: 32416891
[23]	Takeshita S, Todo Y, Okamoto K, et al. Incidence of metastasis in circumflex iliac nodes distal to the external iliac nodes in cervical cancer[J]. J Gynecol Oncol, 2016,27(4):e42. doi: 10.3802/jgo.2016.27.e42. pmid: 27102250
[24]	Yamazaki H, Todo Y, Takeshita S, et al. Relationship between removal of circumflex iliac nodes distal to the external iliac nodes and postoperative lower-extremity lymphedema in uterine cervical cancer[J]. Gynecol Oncol, 2015,139(2):295-299. doi: 10.1016/j.ygyno.2015.09.007. doi: 10.1016/j.ygyno.2015.09.007 pmid: 26363210
[25]	Allam O, Park KE, Chandler L, et al. The impact of radiation on lymphedema: a review of the literature[J]. Gland Surg, 2020,9(2):596-602. doi: 10.21037/gs.2020.03.20. doi: 10.21037/gs.2020.03.20 pmid: 32420295
[26]	Yang J, Cai H, Xiao ZX, et al. Effect of radiotherapy on the survival of cervical cancer patients: An analysis based on SEER database[J]. Medicine (Baltimore), 2019,98(30):e16421. doi: 10.1097/MD.0000000000016421.
[27]	Mohanty SK, Chopra S, Mudaliar A, et al. A comparative analysis of quality of life after postoperative intensity-modulated radiotherapy or three-dimensional conformal radiotherapy for cervical cancer[J]. Indian J Cancer, 2018,55(4):327-335. doi: 10.4103/ijc.IJC_453_17. doi: 10.4103/ijc.IJC_453_17 pmid: 30829265
[28]	Dapper H, Rodríguez I, Münch S, et al. Impact of VMAT-IMRT compared to 3D conformal radiotherapy on anal sphincter dose distribution in neoadjuvant chemoradiation of rectal cancer[J]. Radiat Oncol, 2018,13(1):237. doi: 10.1186/s13014-018-1187-7. pmid: 30509284
[29]	王璐璐, 孔为民. 放疗新技术在子宫颈癌治疗中应用的进展[J]. 中华妇产科杂志, 2013,48(10):792-794. doi: 10.3760/cma.j.issn.0529-567x.2013.10.017.